ASTRO: Intensity-Modulated RT, Proton Beam Therapy Have Similar Outcomes in Prostate Cancer
FRIDAY, Oct. 4, 2024 (HealthDay News) — Intensity-modulated radiation therapy and proton beam therapy offer similar outcomes for patients with localized prostate cancer, according to a study presented at the annual meeting of the American Society for Radiation Oncology, held from Sept. 29 to Oct. 2 in Washington, D.C.
ASTRO: Hypofractionated Radiation Therapy Safe After Breast Reconstruction
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — For patients undergoing breast reconstruction, a 16-fraction course of hypofractionated postmastectomy radiation therapy is noninferior to a 25-fraction conventional course, according to a study presented at the annual meeting of the American Society for Radiation Oncology, held from Sept. 29 to Oct. 2 in Washington, D.C.
Eye Clinicians Identify Features of Vitreoretinal Lymphoma Presentation 
Comparable Progression Risk Seen With Ablation Versus Surgery for T1a Renal Cell Carcinoma 
Physicians Have Modestly Higher Likelihood of Dying at Home or Hospice 
New-Onset Mental Health Issue After Cancer Diagnosis Tied to Higher Risk for Death 
AI Chatbots Often Used by Teens for Mental Health Advice 
Outpatient Benzodiazepine Treatment Down in U.S. Adults From 2018 to 2022 
Mental Health Issues Peak Again More Than a Decade After Disasters 
Living in Closer Proximity to Nuclear Power Plants May Increase Cancer Mortality Risk 
